Colon Cancer Clinical Trial

Pre-Habilitation Exercise Intervention

Summary

The purpose of this study is to see whether exercise can improve the health and well-being of patients scheduled to undergo surgery for a bowel related condition.

View Full Description

Full Description

The proposed randomized controlled trial aims to recruit 60 patients that have a primary diagnosis of either colon or rectal cancer, inflammatory bowl disease, or diverticular disease and are scheduled for elective surgery. This two-arm clinical trial of an intervention examining the efficacy of a home-based walking and progressive resistance exercise program for the relief of post-operative fatigue and improvement of functional outcome following surgery.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Have a primary diagnosis of one of the following: colon or rectal cancer, inflammatory bowel disease, or diverticular disease
Be scheduled for elective (non- emergent) surgery
Have the approval of their treating physician, study physician, or physician's designee to participate in maximal physiological fitness testing and a low to moderate home-based walking and progressive resistance exercise program.
Be able to read English (since the assessment materials will be in a printed format).
Be 18 years of age or older
Give informed consent.

Exclusion Criteria:

Have physical limitations (e.g. cardiorespiratory, orthopedic, central nervous system) that contraindicate participation in maximal physiological fitness testing, or a low to moderate home-based walking and progressive resistance program, as assessed by the Par-Q+ and clinician (or physician's designee)
Must not be in active or maintenance stage of exercise

Study is for people with:

Colon Cancer

Estimated Enrollment:

83

Study ID:

NCT02849717

Recruitment Status:

Recruiting

Sponsor:

University of Rochester

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Rochester
Rochester New York, 14642, United States More Info
Fergal Fleming, MD
Contact
585-273-2727
[email protected]
Ila Marianetti, BA
Contact
[email protected]
Fergal Fleming, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

83

Study ID:

NCT02849717

Recruitment Status:

Recruiting

Sponsor:


University of Rochester

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.